R. Sawada

Comparison of anti-inflammatory effects of rivaroxaban vs. dabigatran in patients with non-valvular atrial fibrillation (RIVAL-AF study): multicenter randomized study

J. Okuda, Kengo Tsukahara, Y. Mochida, 2018, Heart and Vessels.

Clinical usefulness of additional treatment with ezetimibe in patients with coronary artery disease on statin therapy. - From the viewpoint of cholesterol metabolism.-.

S. Umemura, K. Uchino, Y. Mochida, 2011, Circulation journal : official journal of the Japanese Circulation Society.

Clinical course of 2019 novel coronavirus disease (COVID-19) in individuals present during the outbreak on the Diamond Princess cruise ship

I. Takeuchi, Katsuaki Tanaka, H. Shimizu, 2020, Journal of Infection and Chemotherapy.

Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction?

J. Higaki, N. Ohte, T. Murohara, 2017, Cardiovascular Drugs and Therapy.

Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease.

S. Umemura, K. Uchino, Y. Mochida, 2012, Atherosclerosis.

Cardiovascular Outcomes in Patients With Previous Myocardial Infarction and Mild Diabetes Mellitus Following Treatment With Pioglitazone: Reports of a Randomised Trial From The Japan Working Group for the Assessment Whether Pioglitazone Protects DM Patients Against Re-Infarction (PPAR Study).

N. Ohte, T. Murohara, H. Asanuma, 2018, EClinicalMedicine.